You have 9 free searches left this month | for more free features.

stage III multiple myeloma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 30, 2022

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,

Active, not recruiting
  • Stage I Multiple Myeloma
  • +2 more
  • Chicago, Illinois
  • +4 more
Sep 3, 2022

Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)

Recruiting
  • Multiple Myeloma in Relapse
  • +5 more
  • London, Ontario, Canada
    London Health Sciences Centre
Oct 3, 2022

Defining Clinical Potential of Mass Response asBiomarker for

Recruiting
  • Stage III Breast Cancer
  • +5 more
    • Columbus, Georgia
      Columbus Regional Research Institute, John B. Amos Cancer Center
    Jul 13, 2022

    ISS Stage I Plasma Cell Myeloma, ISS Stage II Plasma Cell Myeloma, ISS Stage III Plasma Cell Myeloma Trial in Atlanta

    Active, not recruiting
    • ISS Stage I Plasma Cell Myeloma
    • +4 more
    • Pembrolizumab
    • Radiation Therapy
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Mar 2, 2022

    Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,

    Completed
    • Refractory Multiple Myeloma
    • +4 more
    • total marrow irradiation
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Feb 25, 2021

    Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Bronx, Manhasset, New York (aflibercept)

    Terminated
    • Stage II Multiple Myeloma
    • Stage III Multiple Myeloma
    • aflibercept
    • Bronx, New York
    • +5 more
    Jan 29, 2021

    Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)

    Completed
    • Multiple Myeloma and Plasma Cell Neoplasm
    • Neurotoxicity
    • Duarte, California
      City of Hope Medical Center
    Aug 17, 2021

    ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

    Not yet recruiting
    • ISS Stage III Plasma Cell Myeloma
    • Plasma Cell Myeloma
    • Bone Marrow Aspiration and Biopsy
    • +7 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 9, 2022

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

    Completed
    • Adult Grade III Lymphomatoid Granulomatosis
    • +88 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Apr 14, 2021

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Collecting Blood Samples From and Without Cancer to Evaluate

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +61 more
    • Questionnaire Administration
    • Biospecimen Collection
    • (no location specified)
    Apr 12, 2022

    Multiple Myeloma and Plasma Cell Tumor Trial in United States (arsenic trioxide, dexamethasone)

    Terminated
    • Multiple Myeloma and Plasma Cell Neoplasm
    • Tucson, Arizona
    • +9 more
    Oct 2, 2020

    Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

    Terminated
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 4, 2023

    Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Carfilzomib Lenalidomide Dexamethasone
    • Isatuximab Carfilzomib Lenalidomide Dexamethasone
    • Ostrava, Czechia
    • +6 more
    Jul 26, 2022

    Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Curcumin plus Piperine
    • Rochester, New York
      University of Rochester
    Jun 17, 2022

    Multiple Myeloma Trial in Torino (Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Torino, Italy
      FO.NE.SA.Onlus
    Mar 24, 2022

    Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

    Completed
    • Hematopoietic/Lymphoid Cancer
    • +135 more
    • beclomethasone dipropionate
    • +4 more
    • Hackensack, New Jersey
    • +1 more
    Feb 1, 2021

    Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,

    Recruiting
    • Multiple Myeloma in Relapse
    • Daratumumab/Lenalidomide/Dexamethasone for 24 months
    • Daratumumab/Lenalidomide/Dexamethasone until progression
    • Paris, France
      Saint Antoine Hospital - Hematology Department
    Jun 10, 2022

    DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in Jacksonville,

    Completed
    • DS Stage I Plasma Cell Myeloma
    • +3 more
    • Autologous Bone Marrow Transplantation
    • +4 more
    • Jacksonville, Florida
    • +1 more
    Aug 18, 2020

    National Cancer Institute "Cancer Moonshot Biobank"

    Recruiting
    • Acute Myeloid Leukemia
    • +33 more
    • Biospecimen Collection
    • Medical Chart Review
    • Kingman, Arizona
    • +99 more
    Nov 3, 2022

    Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

    Recruiting
    • Multiple Myeloma
    • Aachen, Germany
    • +29 more
    Apr 4, 2023

    DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in New Brunswick, Bronx,

    Completed
    • DS Stage I Plasma Cell Myeloma
    • +3 more
    • New Brunswick, New Jersey
    • +3 more
    Aug 11, 2020

    Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

    Not yet recruiting
    • Plasma Cell Myeloma
    • (no location specified)
    Dec 22, 2022

    Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

    Active, not recruiting
    • Autologous Hematopoietic Stem Cell Transplant Recipient
    • +4 more
    • Duarte, California
      City of Hope
    Mar 17, 2022